Gilead Sciences reported $4.2B in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
ALKERMES ALKS:US USD 313M 2.32M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 3.91B 504M
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Eli Lilly And LLY:US USD 5.27B 12.8M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Glaxosmithkline GSK:US GBP 6.64B 790M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Merk MRK:US USD 10.97B 1.31B
Moderna Inc MRNA:US USD 2.2B 104M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Puma Biotechnology PBYI:US USD 54.71M 7.19M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
United Therapeutics UTHR:US USD 201.7M 63.4M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
YTE INCY:US USD 684.93M 27.96M